Welcome to LookChem.com Sign In|Join Free
  • or
H-TRP-MET-OH, also known as hydroxytryptophan-methionine-alcohol, is a chemical compound composed of the amino acids tryptophan and methionine. It is widely utilized in the fields of biochemistry and pharmaceutical research as a fundamental building block for peptides and proteins, as well as a substrate for enzyme assays. H-TRP-MET-OH also plays a significant role in the synthesis of pharmaceutical drugs and the development of innovative therapeutic agents, with potential applications in treating a range of diseases and conditions, such as neurological disorders, cancer, and metabolic disorders. H-TRP-MET-OH is instrumental in propelling forward medical science and drug discovery.
Used in Biochemistry Research:
H-TRP-MET-OH is used as a building block for peptides and proteins, facilitating the study and development of novel bioactive molecules.
Used in Pharmaceutical Research:
H-TRP-MET-OH is used as a substrate for enzyme assays, aiding in the understanding of enzyme functions and the development of new drugs.
Used in Drug Synthesis:
H-TRP-MET-OH is used as a key component in the synthesis of pharmaceutical drugs, contributing to the creation of new medications.
Used in the Development of Therapeutic Agents:
H-TRP-MET-OH is used in the development of novel therapeutic agents, potentially leading to new treatments for various diseases and conditions.
Used in the Treatment of Neurological Disorders:
H-TRP-MET-OH is used as a potential therapeutic agent for neurological disorders, aiming to alleviate symptoms and improve patient outcomes.
Used in Cancer Therapy:
H-TRP-MET-OH is used in the development of cancer treatments, potentially contributing to more effective therapies for cancer patients.
Used in Metabolic Disorder Treatment:
H-TRP-MET-OH is used in the treatment of metabolic disorders, helping to regulate and manage these conditions for improved health outcomes.

21438-63-1

Post Buying Request

21438-63-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

21438-63-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 21438-63-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,1,4,3 and 8 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 21438-63:
(7*2)+(6*1)+(5*4)+(4*3)+(3*8)+(2*6)+(1*3)=91
91 % 10 = 1
So 21438-63-1 is a valid CAS Registry Number.

21438-63-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name (2S)-2-[[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]amino]-4-methylsulfanylbutanoic acid

1.2 Other means of identification

Product number -
Other names L-Methionine,L-tryptophyl

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:21438-63-1 SDS

21438-63-1Upstream product

21438-63-1Downstream Products

21438-63-1Relevant academic research and scientific papers

Solid-state stability studies of cholecystokinin (CCK-4) peptide under nonisothermal conditions using thermal analysis, chromatography and mass spectrometry

Oliva, Alexis,Ashen, David Sánchez,Salmona, Mario,Fari?a, José B.,Llabrés, Matías

experimental part, p. 263 - 271 (2011/05/15)

The solid-state stability of cholecystokinin (CCK-4) peptide under nonisothermal conditions was studied by differential scanning calorimetry (DSC), chromatography and mass spectrometry, identifying and schematizing the degradation products. To model the degradation mechanism of the peptide using the combined Kissinger and direct-differential methods, the observed degradation process was characterized by decomposition temperature (Tm), reacted fraction (αm), activation energy (Ea), and pre-exponential factor (A). Results obtained by the two calculation methods were similar. The cleavage reaction on both N- and C-terminal sides of aspartic acid was the principal degradation pathway, although the reaction can occur consecutively and/or in parallel. Therefore to determine the relative importance of the different degradation pathways, a system of differential equations relevant to each degradation reaction was analysed using the R statistical program. The results obtained show that the consecutive reaction was the less plausible, whereas a slightly better fit was obtained for the reaction with both processes than for the in-parallel reaction. In this situation, the F-test was applied to discriminate between the models, indicating that the simpler model is the most probable. In conclusion, the results demonstrate for the first time that, in solid-state, n - 1 cleavage occurs in parallel to n + 1 cleavage at aspartic acid residues and not consecutively.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 21438-63-1